
Sign up to save your podcasts
Or


Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.
By Modern Optometry5
1515 ratings
Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.

76 Listeners

1,134 Listeners

9,216 Listeners

8,527 Listeners

64 Listeners

81 Listeners

532 Listeners

5 Listeners

19 Listeners

20 Listeners

805 Listeners

21 Listeners

376 Listeners

18 Listeners

18 Listeners